APOE gene variants (ε2, ε3, ε4) influence not only lipid metabolism but also glucose homeostasis. Carriers of APOE ε4 have a higher risk of insulin resistance and type 2 diabetes, even after adjusting for BMI. Studies link ε4 to elevated fasting glucose and HbA1c levels. Additionally, impaired glucose tolerance may compound cardiovascular risk in ε4 carriers. APOE ε2 appears protective but can be associated with hypertriglyceridemia. If you know your APOE status, monitor fasting blood glucose, HbA1c, and a full lipid panel regularly. The effects are modest and modifiable by diet, exercise, and weight management. A genetic test alone is not diagnostic but can guide personalized prevention. Caveat: Evidence comes from association studies; targeted interventions based on APOE are not yet clinically established.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-45407e3410b82ab466899ab1